Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $20.2300 (-1.37%) ($20.1500 - $20.6800) on Mon. Oct. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 67 | Latest Price | $20.2300(-1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 5.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.445% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-9%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $20.42(-0.93%) | 10 Day Moving Average | $19.83(2.02%) | 20 Day Moving Average | $19.29(4.87%) | To recent high | -19.6% | To recent low | 12.7% | Market Cap | $2.962b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |